financial post
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate
Financial Post • 4 MONTHS AGO
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Neoadjuvant/Adjuvant NSCLC Treatment
Financial Post • 4 MONTHS AGO
Audiense Launches MCP Connectors: Bringing Audience Intelligence into your AI Workflow
Financial Post • 4 MONTHS AGO
Iveco Group N.V. to present its 2025 Second Quarter Results on 31st July 2025
Financial Post • 4 MONTHS AGO